The right Timing, right combination, right sequence, and right delivery for Cancer immunotherapy

Kwon, M; Jung, H; Nam, GH; Kim, IS

Kim, IS (corresponding author), Korea Univ, KU KIST Grad Sch Converging Sci & Technol, Seoul, South Korea.; Kim, IS (corresponding author), Korea Inst Sci & Technol KIST, Biomed Res Inst, Ctr Theragnosis, Seoul, South Korea.

JOURNAL OF CONTROLLED RELEASE, 2021; 331 (): 321

Abstract

Cancer immunotherapy (CI) represented by immune checkpoint inhibitors (ICIs) presents a new paradigm for cancer treatment. However, the types of cance......

Full Text Link